NCT00397566View on ClinicalTrials.gov

A Multiple Ascending Dose Study of BMS-707035 in HIV-1 Infected Subjects

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

February 28, 2007

Study Completion Date

February 28, 2007

Conditions
HIV Infections
Interventions
DRUG

HIV Integrase Inhibitor (BMS-707035)

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY